Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

Summary: The highly lethal brain cancer glioblastoma (GBM) poses a daunting challenge because the blood-brain barrier renders potentially druggable amplified or mutated oncoproteins relatively inaccessible. Here, we identify sphingomyelin phosphodiesterase 1 (SMPD1), an enzyme that regulates the con...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Cell Reports
المؤلفون الرئيسيون:	Junfeng Bi, Atif Khan, Jun Tang, Aaron M. Armando, Sihan Wu, Wei Zhang, Ryan C. Gimple, Alex Reed, Hui Jing, Tomoyuki Koga, Ivy Tsz-Lo Wong, Yuchao Gu, Shunichiro Miki, Huijun Yang, Briana Prager, Ellis J. Curtis, Derek A. Wainwright, Frank B. Furnari, Jeremy N. Rich, Timothy F. Cloughesy, Harley I. Kornblum, Oswald Quehenberger, Andrey Rzhetsky, Benjamin F. Cravatt, Paul S. Mischel
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2021-11-01
الموضوعات:	glioblastoma sphingolipid metabolism SMPD1 fluoxetine Membrane lipids EGFR signaling
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2211124721014340